b'Table of ContentsExecutive Summary .3Introduction .3LE&RN Global Registry for Lymphatic DiseasesStudy Methodology .5Key Indicators 6Discussion 14Challenges and Limitations 16Recommendations for the Future 17Case Studies: Patient Voices 17Future Directions . 18Acknowledgements . 18References . 19Appendices . 20|National Indicator Report on Cancer-Related Lymphedema (LE)|2'